Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation

被引:6
|
作者
Inamoto, Yoshihiro [1 ]
Petricek, Igor [2 ]
Burns, Linda [3 ]
Chhabra, Saurabh [4 ]
DeFilipp, Zachariah [5 ]
Hematti, Peiman [6 ]
Rovo, Alicia [7 ]
Schears, Raquel [8 ]
Shah, Ami [9 ]
Agrawal, Vaibhav [10 ]
Ahmed, Aisha [11 ]
Ahmed, Ibrahim [12 ]
Ali, Asim [13 ]
Aljurf, Mahmoud [14 ]
Alkhateeb, Hassan [8 ]
Beitinjaneh, Amer [15 ]
Bhatt, Neel [16 ]
Buchbinder, Dave [17 ]
Byrne, Michael [18 ]
Callander, Natalie [19 ]
Fahnehjelm, Kristina [20 ,21 ]
Farhadfar, Nosha [22 ]
Gale, Robert Peter [23 ]
Ganguly, Siddhartha [24 ]
Hashmi, Shahrukh [14 ]
Hildebrandt, Gerhard C. [25 ]
Horn, Erich [22 ]
Jakubowski, Ann [26 ]
Kamble, Rammurti T. [27 ]
Law, Jason [28 ]
Lee, Catherine [29 ]
Nathan, Sunita [30 ]
Penack, Olaf [31 ]
Pingali, Ravi [32 ]
Prasad, Pinki [33 ]
Pulanic, Drazen [34 ,35 ,36 ]
Rotz, Seth [37 ]
Shreenivas, Aditya [38 ]
Steinberg, Amir [38 ]
Tabbara, Khalid [39 ]
Tichelli, Andre [40 ]
Wirk, Baldeep [41 ]
Yared, Jean [42 ]
Basak, Grzegorz W. [43 ]
Battiwalla, Minoo [44 ]
Duarte, Rafael [45 ]
Savani, Bipin N. [18 ]
Flowers, Mary E. D. [46 ]
Shaw, Bronwen E. [16 ]
Valdes-Sanz, Nuria [47 ]
机构
[1] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo, Japan
[2] Zagreb Univ Clin Hosp, Dept Ophthalmol, Zagreb, Croatia
[3] Natl Marrow Donor Program Be Match, Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA
[4] Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA
[5] Massachusetts Gen Hosp, Blood & Marrow Transplant Program, Boston, MA 02114 USA
[6] Univ Wisconsin Hosp & Clin, Dept Med, Div Hematol Oncol Bone Marrow Transplantat, Madison, WI 53792 USA
[7] Bern Univ Hosp, Inselspital, Bern, Switzerland
[8] Mayo Clin Rochester, Div Hematol, Rochester, MN USA
[9] Lucille Packard Childrens Hosp, Stanford Sch Med, Div Stem Cell Transplantat & Regenerat Med, Palo Alto, CA 94304 USA
[10] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[11] Univ Calif San Francisco, San Francisco, CA 94143 USA
[12] Childrens Mercy Hosp & Clin, Dept Hematol Oncol & Bone Marrow Transplantat, Kansas City, MO USA
[13] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON, Canada
[14] King Faisal Specialist Hosp & Res Ctr, Dept Oncol, Riyadh, Saudi Arabia
[15] Univ Miami, Miami, FL USA
[16] Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Program, Milwaukee, WI 53226 USA
[17] Childrens Hosp Orange Cty, Div Pediat Hematol, Orange, CA 92668 USA
[18] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA
[19] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
[20] Karolinska Inst, St Erik Eye Hosp, Dept Clin Neurosci, Stockholm, Sweden
[21] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden
[22] Univ Florida, Hlth Shands Hosp, Gainesville, FL USA
[23] Imperial Coll London, Hematol Res Ctr, Dept Med, Div Expt Med, London, England
[24] Univ Kansas Hlth Syst, Div Hematol Malignancy & Cellular Therapeut, Kansas City, KS USA
[25] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA
[26] Mem Sloan Kettering Canc Ctr, Div Hematol Oncol, 1275 York Ave, New York, NY 10021 USA
[27] Baylor Coll Med, Ctr Cell & Gene Therapy, Div Hematol & Oncol, Houston, TX 77030 USA
[28] Tufts Med Ctr, Boston, MA 02111 USA
[29] Univ Utah, Utah Blood & Marrow Transplant Program, Huntsman Canc Inst, Salt Lake City, UT USA
[30] Rush Univ, Med Ctr, Chicago, IL 60612 USA
[31] Charite, Dept Internal Med, Div Hematol & Oncol, Campus Rudolf Virchow, Berlin, Germany
[32] Houston Methodist Hosp, Houston, TX 77030 USA
[33] Lousiana State Univ Childrens Hosp, New Orleans, LA USA
[34] Univ Hosp Ctr Zagreb, Dept Internal Med, Div Hematol, Zagreb, Croatia
[35] Univ Zagreb, Sch Med, Zagreb, Croatia
[36] Josip Juraj Strossmayer Univ Osijek, Fac Med, Osijek, Croatia
[37] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[38] Mt Sinai Hosp, Div Hematol & Oncol, New York, NY 10029 USA
[39] Johns Hopkins Med, Wilmer Eye Inst, Baltimore, MD USA
[40] Univ Hosp Basel, Hematol, Basel, Switzerland
[41] Seattle Canc Care Alliance, Div Bone Marrow Transplant, Washington, DC USA
[42] Univ Maryland, Dept Med, Greenebaum Comprehens Canc Ctr, Div Hematol Oncol,Blood & Marrow Transplantat Pro, Baltimore, MD 21201 USA
[43] Med Univ Warsaw, Dept Hematol Oncol & Internal Med, Warsaw, Poland
[44] Sarah Cannon Ctr Blood Canc, Hematol Branch, Nashville, TN USA
[45] Puerta de Hierro Majadahonda Univ Hosp, Hematopoiet Transplantat & Hematooncol Sect, Madrid, Spain
[46] Fred Hutchinson Canc Res Ctr, Clin Res Div, 1124 Columbia St, Seattle, WA 98104 USA
[47] Puerta de Hierro Majadahonda Univ Hosp, Dept Ophthalmol, Madrid, Spain
关键词
Hematopoietic cell; transplantation; Complication; Eye; Review; Prevention; Treatment; NERVOUS-SYSTEM LYMPHOMA; TERM-FOLLOW-UP; CYTOMEGALOVIRUS RETINITIS; RISK-FACTORS; RANDOMIZED-TRIAL; MACULAR EDEMA; RETINAL MICROVASCULOPATHY; INTRAOCULAR-PRESSURE; ADENOVIRUS INFECTION; TOXOPLASMA-GONDII;
D O I
10.1016/j.bbmt.2018.11.033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Non-graft-versus-host disease (GVHD) ocular complications are generally uncommon after hematopoietic cell transplantation (HCT) but can cause prolonged morbidity affecting activities of daily living and quality of life. Here we provide an expert review of non-GVHD ocular complications in a collaboration between transplantation physicians and ophthalmologists through the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. Complications discussed in this review include cataracts, glaucoma, ocular infections, ocular involvement with malignancy, ischemic microvascular retinopathy, central retinal vein occlusion, retinal hemorrhage, retinal detachment and ocular toxicities associated with medications. We summarize the incidence, risk factors, screening, prevention, and treatment of individual complications and generate evidence-based recommendations. Baseline ocular evaluation before HCT should be considered in all patients who undergo HCT. Follow-up evaluations should be considered according to clinical signs and symptoms and risk factors. Better preventive strategies and treatments remain to be investigated for individual ocular complications after HCT. Both transplantation physicians and ophthalmologists should be knowledgeable about nonGVHD ocular complications and provide comprehensive collaborative team care. (C) 2018 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:E145 / E154
页数:10
相关论文
共 34 条
  • [1] Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT
    Inamoto, Yoshihiro
    Petricek, Igor
    Burns, Linda
    Chhabra, Saurabh
    DeFilipp, Zack
    Hematti, Peiman
    Rovo, Alicia
    Schears, Raquel
    Shah, Ami
    Agrawall, Vaibhav
    Al-Khinji, Aisha
    Ahmed, Ibrahim
    Ali, Asim
    Aljurf, Mahmoud
    Alkhateeb, Hassan
    Beitinjaneh, Amer
    Bhatt, Neel
    Buchbinder, Dave
    Byrne, Michael
    Callander, Natalie
    Fahnehjelm, Kristina
    Farhadfar, Nosha
    Gale, Robert Peter
    Ganguly, Siddhartha
    Hildebrandt, Gerhard C.
    Horn, Erich
    Jakubowski, Ann
    Kamble, Rammurti T.
    Law, Jason
    Lee, Catherine
    Nathan, Sunita
    Penack, Olaf
    Pingali, Ravi
    Prasad, Pinki
    Pulanic, Drazen
    Rotz, Seth
    Shreenivas, Aditya
    Steinberg, Amir
    Tabbara, Khalid
    Tichelli, Andre
    Wirk, Baldeep
    Yared, Jean
    Basak, Grzegorz W.
    Battiwalla, Minoo
    Duarte, Rafael
    Savani, Bipin N.
    Flowers, Mary E. D.
    Shaw, Bronwen E.
    Valdes-Sanz, Nuria
    BONE MARROW TRANSPLANTATION, 2019, 54 (05) : 648 - 661
  • [2] Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT
    Inamoto, Yoshihiro
    Valdes-Sanz, Nuria
    Ogawa, Yoko
    Alves, Monica
    Berchicci, Luigi
    Galvin, John
    Greinix, Hildegard
    Hale, Gregory A.
    Horn, Biljana
    Kelly, Debra
    Liu, Hien
    Rowley, Scott
    Schoemans, Helene
    Shah, Ami
    Stanghellini, Maria Teresa Lupo
    Agrawal, Vaibhav
    Ahmed, Ibrahim
    Ali, Asim
    Bhatt, Neel
    Byrne, Michael
    Chhabra, Saurabh
    DeFilipp, Zachariah
    Fahnehjelm, Kristina
    Farhadfar, Nosha
    Horn, Erich
    Lee, Catherine
    Nathan, Sunita
    Penack, Olaf
    Prasad, Pinki
    Rotz, Seth
    Rovo, Alicia
    Yared, Jean
    Pavletic, Steven
    Basak, Grzegorz W.
    Battiwalla, Minoo
    Duarte, Rafael
    Savani, Bipin N.
    Flowers, Mary E. D.
    Shaw, Bronwen E.
    Petricek, Igor
    BONE MARROW TRANSPLANTATION, 2019, 54 (05) : 662 - 673
  • [3] Late Effects in Hematopoietic Cell Transplant Recipients with Acquired Severe Aplastic Anemia: A Report from the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research
    Buchbinder, David
    Nugent, Diane J.
    Brazauskas, Ruta
    Wang, Zhiwei
    Aljurf, Mahmoud D.
    Cairo, Mitchell S.
    Chow, Robert
    Duncan, Christine
    Eldjerou, Lamis K.
    Gupta, Vikas
    Hale, Gregory A.
    Halter, Joerg
    Hayes-Lattin, Brandon M.
    Hsu, Jack W.
    Jacobsohn, David A.
    Kamble, Rammurti T.
    Kasow, Kimberly A.
    Lazarus, Hillard M.
    Mehta, Paulette
    Myers, Kasiani C.
    Parsons, Susan K.
    Passweg, Jakob R.
    Pidala, Joseph
    Reddy, Vijay
    Sales-Bonfim, Carmen M.
    Savani, Bipin N.
    Seber, Adriana
    Sorror, Mohamed L.
    Steinberg, Amir
    Wood, William A.
    Wall, Donna A.
    Winiarski, Jacek H.
    Yu, Lolie C.
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (12) : 1776 - 1784
  • [4] Peripheral blood stem cell versus bone marrow transplantation: A perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Byrne, Michael
    Savani, Bipin N.
    Mohty, Mohamad
    Nagler, Arnon
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (07) : 567 - 573
  • [5] Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation:: Joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation
    Rizzo, JD
    Wingard, YR
    Tichelli, A
    Lee, SJ
    Van Lint, MT
    Burns, LJ
    Davies, SM
    Ferrara, JLM
    Socié, G
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 138 - 151
  • [6] Feasibility and Outcomes of a Third Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Rank, Andreas
    Peczynski, Christophe
    Labopin, Myriam
    Stelljes, Matthias
    Simand, Celestine
    Helbig, Grzegorz
    Finke, Jurgen
    Santarone, Stella
    Tischer, Johanna
    Lange, Andrzej
    Mistrik, Martin
    Houhou, Mohamed
    Schmid, Christoph
    Nagler, Arnon
    Mohty, Mohamad
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (05): : 408.e1 - 408.e6
  • [7] Malignancies after Hematopoietic Cell Transplantation for Primary Immune Deficiencies: A Report from the Center for International Blood and Marrow Transplant Research
    Kamani, Naynesh R.
    Kumar, Shimareet
    Hassebroek, Anna
    Eapen, Mary
    LeRademacher, Jennifer
    Casper, James
    Cowan, Morton
    de Toledo, Jose Sanchez
    Ferster, Alina
    Szabolcs, Paul
    Wingard, John R.
    Horwitz, Edwin
    Filipovich, Alexandra H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (12) : 1783 - 1789
  • [8] Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation:: Joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT)
    Rizzo, JD
    Wingard, JR
    Tichelli, A
    Lee, SJ
    Van Lint, MT
    Burns, LJ
    Davies, SM
    Ferrara, JLM
    Socié, G
    BONE MARROW TRANSPLANTATION, 2006, 37 (03) : 249 - 261
  • [9] Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Baron, Frederic
    Mohty, Mohamad
    Blaise, Didier
    Socie, Gerard
    Labopin, Myriam
    Esteve, Jordi
    Ciceri, Fabio
    Giebel, Sebastian
    Gorin, Norbert Claude
    Savani, Bipin N.
    Schmid, Christoph
    Nagler, Arnon
    HAEMATOLOGICA, 2017, 102 (02) : 224 - 234
  • [10] Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT)
    J D Rizzo
    J R Wingard
    A Tichelli
    S J Lee
    M T Van Lint
    L J Burns
    S M Davies
    J L M Ferrara
    G Socié
    Bone Marrow Transplantation, 2006, 37 : 249 - 261